The 20 Best Fibrolamellar Carcinoma Doctors Near Me in Daly City, CA

Dr. John Gordan is a gastrointestinal cancer specialist who cares for patients with hepatobiliary cancers, such as cholangiocarcinoma (bile duct cancer), hepatocellular carcinoma (the most common liver cancer) and gallbladder cancer. Gordan is actively involved in designing and carrying out clinical trials of potential treatments for hepatocellular carcinoma and cholangiocarcinoma. His laboratory research focuses on identifying new therapies for patients with these cancers as well as identifying predictive biomarkers to better apply existing therapies. Gordan completed his medical degree at the University of Pennsylvania, followed by a residency in internal medicine and a fellowship in medical oncology at UCSF. He joined the UCSF faculty in 2015. Gordan is a member of the American Society of Clinical Oncology, which supports his research, as does the American Cancer Society. Dr. Gordan is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Gallbladder Adenocarcinoma, and Tissue Biopsy. Dr. Gordan is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Gordan is currently accepting new patients.

Raphael Merriman is a Hepatologist practicing medicine in San Francisco, California. Dr. Merriman is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Alcoholic Cirrhosis, Visceromegaly, Enlarged Liver, and Liver Transplant. Dr. Merriman is board certified in Transplant Hepatology - Board Certified. Dr. Merriman is currently accepting new patients.

Timothy Davern is a Hepatologist practicing medicine in San Francisco, California. Dr. Davern is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Liver Failure, Autoimmune Hepatitis, Liver Transplant, and Endoscopy. Dr. Davern is board certified in Transplant Hepatology - Board Certified. Dr. Davern is currently accepting new patients.

Adil Wakil is a Hepatologist practicing medicine in San Francisco, California. Dr. Wakil is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Visceromegaly, Liver Failure, Alcoholic Cirrhosis, and Endoscopy. Dr. Wakil is board certified in Transplant Hepatology - Board Certified. Dr. Wakil is currently accepting new patients.

Edward Holt is a Hepatologist practicing medicine in San Francisco, California. Dr. Holt is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Visceromegaly, Enlarged Liver, Myringotomy, and Endoscopy. Dr. Holt is board certified in Transplant Hepatology - Board Certified. Dr. Holt is currently accepting new patients.

Garrett Hisatake is a General Surgeon practicing medicine in San Francisco, California. Dr. Hisatake is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Banti's Syndrome, Hepatitis, Liver Failure, Hepatectomy, and Liver Transplant. Dr. Hisatake is board certified in Surgery - Board Certified. Dr. Hisatake is currently accepting new patients.

Dr. Derek Sun is a radiologist who interprets medical imaging that includes X-rays, ultrasound images, CT scans and MRI. He has a particular interest in diseases and conditions of the abdomen and pelvis. Sun earned his medical degree at Albert Einstein College of Medicine. He completed a residency in radiology at NYC Health + Hospitals/Jacobi, followed by a fellowship in abdominal imaging at UCSF. Sun is passionate about educating physicians-in-training. He serves as associate director of UCSF’s program in abdominal imaging and ultrasound, for which he teaches high-level concepts in medical imaging. He received the Hideyo Minagi Outstanding Teacher Award in 2019. A native San Franciscan, Sun enjoys giving back to his community. He volunteers at a local food bank and promotes STEM education (science, technology, engineering and mathematics) to Bay Area students. Dr. Sun is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Chronic Cough, Fibrolamellar Carcinoma, WT1-Related Wilms Tumor Syndromes, Progressive Familial Intrahepatic Cholestasis Type 1, and Small Bowel Resection. Dr. Sun is board certified in American Board Of Radiology, Diagnostic Radiology. Dr. Sun is currently accepting new patients.

Robert Weber is a Hematologist and an Oncologist practicing medicine in Daly City, California. Dr. Weber is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Weber is board certified in Internal Medicine (Sub: Medical Oncology), Internal Medicine (Sub: Hematology), and Internal Medicine. Dr. Weber is currently accepting new patients.

Jin Yoo is a Radiologist practicing medicine in San Francisco, California. Dr. Yoo is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Pleurisy, Pleural Effusion, ALK-Positive Non-Small Cell Lung Cancer, and Fibrolamellar Carcinoma.

Arash Meshksar is a Radiologist practicing medicine in San Francisco, California. Dr. Meshksar is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Chronic Inflammatory Response Syndrome (CIRS), Progressive Familial Intrahepatic Cholestasis Type 2, Progressive Familial Intrahepatic Cholestasis Type 3, and Progressive Familial Intrahepatic Cholestasis Type 1.

Stephen Abedon is a Radiologist practicing medicine in Daly City, California. Dr. Abedon is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Pleural Effusion, Pleurisy, Thyroid Nodule, Liver Embolization, and Bone Marrow Aspiration.

Jonathan Tran is a Radiologist practicing medicine in Daly City, California. Dr. Tran is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Chronic Inflammatory Response Syndrome (CIRS), Progressive Familial Intrahepatic Cholestasis Type 3, Progressive Familial Intrahepatic Cholestasis Type 2, and Progressive Familial Intrahepatic Cholestasis Type 1.

John Bokelman is a Radiologist practicing medicine in San Francisco, California. Dr. Bokelman is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Breast Lump, Melorheostosis with Osteopoikilosis, Melorheostosis, and Osteopenia.

Dr. Nicholas Fidelman is a radiologist who specializes in caring for patients with liver cancer, metastatic colorectal cancer and neuroendocrine tumors. He has expertise in liver-directed therapy, a treatment that directly targets cancer in the liver. He also is experienced in treating portal hypertension (high blood pressure in the veins connecting the digestive organs to the liver), biliary disorders (which affect the bile ducts and gallbladder), urinary system disorders, and in performing dialysis interventions (minimally invasive procedures to restore blood flow in vessels used for dialysis). Fidelman's research focuses on clinical trials investigating novel treatments for liver cancer, outcomes of commonly performed procedures in interventional radiology, and on improving the safety and efficacy of image-guided treatments. Fidelman earned his medical degree from UCSF, where he also completed a residency in radiology and a fellowship in vascular and interventional radiology. Dr. Fidelman is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Liver Cancer, Ascites, Liver Embolization, and Gastrostomy. Dr. Fidelman is board certified in American Board Of Radiology, Interventional And Diagnostic Radiology. Dr. Fidelman is currently accepting new patients.

Dr. Neil Mehta is a gastroenterologist and specialist in liver transplantation. In his research, Mehta examines liver cancer treatment, particularly as related to liver transplants. He has contributed to important publications in this area. His other research interests include outcomes for patients who undergo liver transplantation and cardiac iron overload in patients with chronic liver disease. He frequently lectures in the community and at the university on these subjects. At the UCSF School of Medicine, Mehta supervises the training of residents as well as fellows in both gastroenterology and liver transplant medicine. He also delivers lectures on liver disease to UCSF medical students studying metabolism and nutrition. Mehta earned his medical degree at UCSF and completed a residency in internal medicine at the University of Pennsylvania. He completed fellowships in gastroenterology and liver transplantation at UCSF. Dr. Mehta is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Visceromegaly, Liver Failure, Alcoholic Cirrhosis, and Liver Transplant. Dr. Mehta is board certified in American Board Of Internal Medicine, Transplant Hepatology. Dr. Mehta is currently accepting new patients.

Dr. Zhen Jane Wang is a radiologist who specializes in abdominal imaging. In research, Wang's interests focus on identifying novel imaging techniques and developing them into practical, useful diagnostic tools. Her research program includes using hyperpolarized 13C metabolic MRI – an advanced imaging technique – to assess kidney tumors' aggressiveness and diffuse kidney disease. She is also interested in quantitative imaging – a technique for measuring features of a tumor by applying algorithms to images – for assessing patients with pancreatic cancer. Wang has received research grants from private and public organizations, including the Society of Abdominal Radiology, Radiological Society of North America, U.S. Department of Defense and National Institutes of Health. In 2019, she received the Distinguished Investigator Award from the Academy for Radiology and Biomedical Imaging Research. After earning a bachelor's degree in electrical engineering at Brown University, Wang earned her medical degree from Northwestern University Feinberg School of Medicine. She completed a residency in diagnostic radiology at UCSF, serving as chief resident. She also completed a fellowship in abdominal imaging at UCSF. She joined the UCSF faculty in 2008. Wang serves as associate director for UCSF's program in biomedical imaging for clinician-scientists and as associate chair for strategic planning in the UCSF Department of Radiology and Biomedical Imaging. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Spontaneous Coronary Artery Dissection (SCAD), Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Pancreaticoduodenectomy, and Percutaneous Coronary Intervention (PCI). Dr. Wang is board certified in American Board Of Radiology/Diagnostic Radiology, Diagnostic Radiology. Dr. Wang is currently accepting new patients.

Dr. Brett M. Elicker is a specialist in thoracic radiology. He has a particular interest in evaluating interstitial lung disease with the advanced imaging techniques of high-resolution computed tomography. Elicker earned his medical degree at New York Medical College. He completed a residency in diagnostic radiology at Yale University and a fellowship in thoracic imaging at UCSF. Dr. Elicker is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Interstitial Lung Disease, Pulmonary Fibrosis, Lung Nodules, and ALK-Positive Non-Small Cell Lung Cancer. Dr. Elicker is board certified in American Board Of Radiology, Diagnostic Radiology. Dr. Elicker is currently accepting new patients.

Dr. Benjamin M. Yeh is a radiologist who specializes in abdominal imaging. He has particular expertise in computed tomography (CT), contrast materials (substances introduced to make certain internal structures more visible), advanced liver imaging, and imaging of the genital and urinary organs. Yeh has received grants from the National Institutes of Health to study and develop novel CT contrast materials. He holds three patents. Yeh earned his medical degree at Duke University. He completed a residency in radiology and a fellowship in abdominal imaging at UCSF. Yeh is active in teaching at UCSF. Dr. Yeh is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Progressive Familial Intrahepatic Cholestasis Type 2, Progressive Familial Intrahepatic Cholestasis Type 1, WT1-Related Wilms Tumor Syndromes, Small Bowel Resection, and Liver Embolization. Dr. Yeh is board certified in American Board Of Radiology, Diagnostic Radiology.

Dr. R. Kate Kelley is a gastrointestinal oncologist who treats liver cancers such as hepatocellular carcinoma; bile duct cancer (cholangiocarcinoma); gastric cancer; esophageal cancer; anal, colon and rectal cancer; pancreatic cancer; and gastrointestinal stromal tumors. Kelley's research interests include developing clinical trials to identify new treatments for gastrointestinal malignancies, particularly hepatocellular carcinoma and bile duct cancer. Kelley graduated from the David Geffen School of Medicine at UCLA and completed a residency at UCLA, where she was chief resident in internal medicine. She also completed a fellowship in hematology and oncology at UCSF. Kelley received the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium Merit Award in 2009 and the ASCO Young Investigator Award in 2010. She co-authored a chapter on digestive tract cancers in the textbook Current Medical Diagnosis and Treatment. Dr. Kelley is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Adenocarcinoma, and Gallbladder Cancer. Dr. Kelley is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Kelley is currently accepting new patients.

Dr. Mary Feng is a radiation oncologist who cares for patients with cancers affecting organs of the abdomen and pelvis. In research, Feng aims to refine radiation therapy so that it's more effective and has fewer side effects through the use of advanced technologies and imaging techniques. Her work includes improving radiation treatment when used alone as well as in combination with chemotherapy and immunotherapy. As vice chair for clinical research in the Department of Radiation Oncology, Feng supervises and encourages innovative clinical trials at UCSF. As the medical director of the Clinical Research Network Office at the Helen Diller Family Comprehensive Cancer Center, she helps local UCSF partners expand clinical trials into the community. Feng earned her medical degree at Washington University School of Medicine in St. Louis. She completed a residency in radiation oncology at the University of Michigan Hospitals. Dr. Feng is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Fibrolamellar Carcinoma, Prostate Cancer, Familial Prostate Cancer, and Pancreaticoduodenectomy. Dr. Feng is board certified in American Board Of Radiology, Radiation Oncology. Dr. Feng is currently accepting new patients.